Bio-Rad Laboratories Total Assets 2006-2020 | BIO

Bio-Rad Laboratories total assets from 2006 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Bio-Rad Laboratories total assets for the quarter ending June 30, 2020 were $10.097B, a 32.04% increase year-over-year.
  • Bio-Rad Laboratories total assets for 2019 were $8.009B, a 42.73% increase from 2018.
  • Bio-Rad Laboratories total assets for 2018 were $5.611B, a 31.31% increase from 2017.
  • Bio-Rad Laboratories total assets for 2017 were $4.273B, a 10.97% increase from 2016.
Bio-Rad Laboratories Annual Total Assets
(Millions of US $)
2019 $8,009
2018 $5,611
2017 $4,273
2016 $3,851
2015 $3,710
2014 $3,341
2013 $3,389
2012 $3,444
2011 $3,097
2010 $3,063
2009 $2,536
2008 $2,037
2007 $1,972
2006 $1,596
2005 $1,427
Bio-Rad Laboratories Quarterly Total Assets
(Millions of US $)
2020-06-30 $10,097
2020-03-31 $8,684
2019-12-31 $8,009
2019-09-30 $7,177
2019-06-30 $7,647
2019-03-31 $6,863
2018-12-31 $5,611
2018-09-30 $6,719
2018-06-30 $6,386
2018-03-31 $6,215
2017-12-31 $4,273
2017-09-30 $4,186
2017-06-30 $4,143
2017-03-31 $3,953
2016-12-31 $3,851
2016-09-30 $4,020
2016-06-30 $3,875
2016-03-31 $3,753
2015-12-31 $3,710
2015-09-30 $3,666
2015-06-30 $3,525
2015-03-31 $3,326
2014-12-31 $3,341
2014-09-30 $3,386
2014-06-30 $3,468
2014-03-31 $3,441
2013-12-31 $3,389
2013-09-30 $3,280
2013-06-30 $3,483
2013-03-31 $3,457
2012-12-31 $3,444
2012-09-30 $3,303
2012-06-30 $3,169
2012-03-31 $3,188
2011-12-31 $3,097
2011-09-30 $2,970
2011-06-30 $3,044
2011-03-31 $2,909
2010-12-31 $3,063
2010-09-30 $2,682
2010-06-30 $2,527
2010-03-31 $2,547
2009-12-31 $2,536
2009-09-30 $2,478
2009-06-30 $2,344
2009-03-31 $1,955
2008-12-31 $2,037
2008-09-30 $2,015
2008-06-30 $2,099
2008-03-31 $2,053
2007-12-31 $1,972
2007-09-30 $1,712
2007-06-30 $1,655
2007-03-31 $1,607
2006-12-31 $1,596
2006-09-30 $1,524
2006-06-30 $1,494
2006-03-31 $1,415
2005-12-31 $1,427
2005-09-30 $1,426
2005-06-30 $1,393
2005-03-31 $1,399
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $15.555B $2.312B
Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials, and to identify, analyze, and purify their components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment offers electrophoresis, image analysis, molecular detection, chromatography, gene transfer, sample preparation, and amplification products and services. The Clinical Diagnostics segment provides control, autoimmune, diabetes, and blood virus testing products. Bio-Rad is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. The company is headquartered in Hercules, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $179.231B 33.63
Medtronic (MDT) Ireland $134.197B 21.80
Stryker (SYK) United States $71.795B 27.84
Boston Scientific (BSX) United States $55.753B 32.21
Lonza Group Ag (LZAGY) Switzerland $46.856B 0.00
Baxter (BAX) United States $40.868B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.859B 23.95
Terumo (TRUMY) Japan $28.725B 36.72
EssilorLuxottica Societe Anonyme (ESLOY) France $28.171B 0.00
ResMed (RMD) United States $25.062B 36.40
Sunny Optical Technology (SNPTF) China $20.566B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $18.308B 0.00
Insulet (PODD) United States $13.735B 604.81
Shandong Weigao Medical Polymer (SHWGF) China $12.315B 0.00
Quidel (QDEL) United States $11.442B 60.61
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Perrigo (PRGO) Ireland $6.885B 11.81
Hill-Rom Holdings (HRC) United States $6.336B 15.72
Canopy Growth (CGC) Canada $6.168B 0.00
Neogen (NEOG) United States $4.337B 72.47
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.204B 0.00
Haemonetics (HAE) United States $4.045B 26.95
Envista Holdings (NVST) United States $3.725B 25.40
ICU Medical (ICUI) United States $3.702B 27.01
Abcam (ABCZY) $3.462B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.396B 0.00
Agios Pharmaceuticals (AGIO) United States $2.988B 0.00
NuVasive (NUVA) United States $2.753B 38.36
National Vision Holdings (EYE) United States $2.678B 416.25
TG Therapeutics (TGTX) United States $2.314B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.945B 0.00
AtriCure (ATRC) United States $1.911B 0.00
MacroGenics (MGNX) United States $1.484B 0.00
NanoString Technologies (NSTG) United States $1.330B 0.00
Aphria (APHA) Canada $1.287B 0.00
Aurora Cannabis (ACB) Canada $1.186B 0.00
Cerus (CERS) United States $1.173B 0.00
Cardiovascular Systems (CSII) United States $1.097B 0.00
InMode (INMD) Israel $1.016B 25.62
OraSure Technologies (OSUR) United States $1.005B 0.00
Quanterix (QTRX) United States $0.942B 0.00
PetIQ (PETQ) United States $0.895B 25.85
Lantheus Holdings (LNTH) United States $0.888B 12.31
Meridian Bioscience (VIVO) United States $0.828B 19.13
Phibro Animal Health (PAHC) United States $0.825B 16.45
Owens & Minor (OMI) United States $0.813B 18.21
Vapotherm (VAPO) United States $0.781B 0.00
Omeros (OMER) United States $0.770B 0.00
BioLife Solutions (BLFS) United States $0.671B 350.33
Surmodics (SRDX) United States $0.650B 71.25
Eagle Pharmaceuticals (EGRX) United States $0.643B 46.08
VAREX IMAGING (VREX) United States $0.640B 15.90
LeMaitre Vascular (LMAT) United States $0.600B 36.62
Zynex (ZYXI) United States $0.591B 51.64
Cytosorbents (CTSO) United States $0.412B 0.00
Viemed Healthcare (VMD) United States $0.393B 14.04
Neptune Wellness Solutions (NEPT) Canada $0.325B 0.00
HEXO (HEXO) $0.319B 0.00
Utah Medical Products (UTMD) United States $0.294B 25.22
Organigram Holdings (OGI) Canada $0.223B 0.00
Chimerix (CMRX) United States $0.211B 0.00
Female Health (VERU) United States $0.208B 0.00
Exagen (XGN) United States $0.179B 0.00
Bovie Medical (APYX) United States $0.171B 0.00
Surface Oncology (SURF) United States $0.170B 0.00
Fonar (FONR) United States $0.166B 14.75
Wound Management Technologies (SMTI) United States $0.153B 0.00
Liberty Health Sciences (LHSIF) Canada $0.128B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.123B 0.00
Evolus (EOLS) United States $0.118B 0.00
Rockwell Medical (RMTI) United States $0.115B 0.00
Chembio Diagnostics (CEMI) United States $0.111B 0.00
Capricor Therapeutics (CAPR) United States $0.093B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
MTech Acquisition (KERN) United States $0.087B 0.00
Nephros (NEPH) United States $0.071B 0.00
United-Guardian (UG) United States $0.069B 15.58
Brainsway (BWAY) Israel $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Akers Biosciences Inc (AKER) United States $0.037B 0.00
GUARDION HEALTH (GHSI) United States $0.035B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Senestech (SNES) United States $0.007B 0.00